Different interventions for preventing postoperative catheter-related bladder discomfort: a systematic review and meta-analysis Shuying LiPing LiHui Li Review 26 February 2022 Pages: 897 - 906
Desmopressin therapy in children and adults: pharmacological considerations and clinical implications Xinyi ChinShao Wei TeoFabian Yap Review 23 February 2022 Pages: 907 - 917
Hydrochlorothiazide use is associated with the risk of cutaneous and lip squamous cell carcinoma: A systematic review and meta-analysis Ana Cláudia de Macedo AndradeFernanda Aragão FelixAntônio de Lisboa Lopes Costa Review 08 March 2022 Pages: 919 - 930
Selective serotonin reuptake inhibitors in the treatment of depression, anxiety, and post-traumatic stress disorder in substance use disorders: a Bayesian meta-analysis Dimy FluyauParoma MitraChristopher G. Pierre Review 05 March 2022 Pages: 931 - 942
Clinical comparative study assessing the effect of ivabradine on neopterin and NT-Pro BNP against standard treatment in chronic heart failure patients Gaidaa M. DogheimIbtsam KhairatRehab H. Werida Clinical Trial Open access 03 March 2022 Pages: 943 - 954
Influence of daily versus alternate-day dosing of vonoprazan on intragastric pH, serum gastrin, and the antiplatelet function of clopidogrel Tomohiro HiguchiMihoko YamadeTakahisa Furuta Pharmacodynamics 20 April 2022 Pages: 955 - 963
Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin gene David A. NielsenRobrina WalkerThomas R. Kosten Pharmacogenetics 26 February 2022 Pages: 965 - 973
Evaluation of CYP2C19 activity using microdosed oral omeprazole in humans Annika ElbeKathrin Isabelle FoersterGerd Mikus Pharmacokinetics and Disposition Open access 03 March 2022 Pages: 975 - 987
Estimation of cefepime, piperacillin, and tazobactam clearance with iohexol-based glomerular filtration rate in paediatric patients Hiie SoeorgAveli NoortootsLenne-Triin Kõrgvee Pharmacokinetics and Disposition 11 March 2022 Pages: 989 - 1001
Pharmacokinetics of mycophenolic acid and external evaluation of two limited sampling strategies of drug exposure in patients with juvenile systematic lupus erythematosus Quentin BeaulieuDaolun ZhangEvelyne Jacqz-Aigrain Pharmacokinetics and Disposition 16 March 2022 Pages: 1003 - 1010
The association between the availability of over the counter codeine and the prevalence of non-medical use Joanna HockenhullDavid M. WoodPaul I. Dargan Pharmacoepidemiology and Prescription 04 March 2022 Pages: 1011 - 1018
Systemic quinolones and risk of retinal detachment III: a nested case–control study using a US electronic health records database Mohamed Kadry TaherJames A. G. CrispoDaniel Krewski Pharmacoepidemiology and Prescription Open access 15 March 2022 Pages: 1019 - 1028
Colorectal cancer chemotherapy: can sex-specific disparities impact on drug toxicities? Silvia De FranciaPaola BerchiallaMaria Valentina Mussa Pharmacoepidemiology and Prescription Open access 22 February 2022 Pages: 1029 - 1038
Reappraising the role of class Ic antiarrhythmics in atrial fibrillation Dimitris TsiachrisIoannis DoundoulakisChristodoulos Stefanadis Point of View 22 February 2022 Pages: 1039 - 1045
Phase I studies in EU: due change in compliance and transparency under the EU clinical trials regulation Christian Martin De Mey Letter to the Editor 23 February 2022 Pages: 1047 - 1048
The European Prescribing Exam: assessing whether European medical students can prescribe rationally and safely Erik M. DonkerDavid J. Brinkman On behalf of the Erasmus+ consortium EuroPE+ and the EACPT Education Working Group Letter to the Editor Open access 03 March 2022 Pages: 1049 - 1051
Does Ramadan fasting affect the therapeutic and clinical outcomes of warfarin? Lukman Thalib Letter to the Editor 11 March 2022 Pages: 1053 - 1054
Authors’ reply to the letter to editor “Does Ramadan Fasting Affect the Therapeutic and Clinical Outcomes of Warfarin?” Kirellos Said AbbasEslam Mohammed RabeaBasel Abdelazeem Letter to the Editor 11 March 2022 Pages: 1055 - 1056